| scholarly article | Q13442814 |
| P50 | author | Christopher S. Chen | Q66020434 |
| P2093 | author name string | Elazer R Edelman | |
| C Keith Ozaki | |||
| Rowza T Rumma | |||
| H-H Greco Song | |||
| P2860 | cites work | The Physiological Principle of Minimum Work: I. The Vascular System and the Cost of Blood Volume | Q24522729 |
| Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures | Q24679747 | ||
| Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. | Q24682828 | ||
| Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization | Q26852191 | ||
| Smooth muscle and other cell sources for human blood vessel engineering | Q26862581 | ||
| Molecular control of endothelial cell behaviour during blood vessel morphogenesis | Q27007664 | ||
| Hypoxia-inducible factors in physiology and medicine | Q27013770 | ||
| Dynamic endothelial cell rearrangements drive developmental vessel regression | Q27312264 | ||
| Local 3D matrix microenvironment regulates cell migration through spatiotemporal dynamics of contractility-dependent adhesions. | Q27319852 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Vascular diseases await translation of blood vessels engineered from stem cells | Q28083072 | ||
| Hydrogels to model 3D in vitro microenvironment of tumor vascularization | Q28383786 | ||
| Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity | Q28509237 | ||
| Taking cell-matrix adhesions to the third dimension | Q29615214 | ||
| Basic and therapeutic aspects of angiogenesis | Q29615219 | ||
| Small-diameter vascular tissue engineering. | Q38108204 | ||
| Engineering of arteries in vitro | Q38176555 | ||
| Shear stress-initiated signaling and its regulation of endothelial function | Q38215992 | ||
| Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights | Q38234710 | ||
| Tissue engineered vascular grafts: Origins, development, and current strategies for clinical application | Q38555494 | ||
| The Host Immune Response to Tissue-Engineered Organs: Current Problems and Future Directions | Q38678371 | ||
| Mechanics of Vascular Smooth Muscle | Q38693274 | ||
| Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9. | Q38695167 | ||
| Multilineage communication regulates human liver bud development from pluripotency. | Q38725847 | ||
| Historical Perspective and Future Direction of Blood Vessel Developments | Q38738903 | ||
| Endoglin controls blood vessel diameter through endothelial cell shape changes in response to haemodynamic cues. | Q38771567 | ||
| Collagen Cross-Linking: Biophysical, Biochemical, and Biological Response Analysis. | Q39029493 | ||
| Engineering of functional, perfusable 3D microvascular networks on a chip | Q39188827 | ||
| Integration of Self-Assembled Microvascular Networks with Microfabricated PEG-Based Hydrogels | Q39260720 | ||
| Vascular heterogeneity and specialization in development and disease. | Q39326100 | ||
| Arterial specification of endothelial cells derived from human induced pluripotent stem cells in a biomimetic flow bioreactor | Q39855073 | ||
| Seeding endothelium onto canine arterial prostheses. The effects of graft design | Q39886892 | ||
| Collagen as a Biomaterial | Q39946722 | ||
| Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association | Q40061255 | ||
| In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease. | Q40116179 | ||
| Conduit options in coronary artery bypass surgery | Q40412001 | ||
| Tissue engineering: creation of long-lasting blood vessels | Q40579851 | ||
| Hypoxia, leptin, and vascular endothelial growth factor stimulate vascular endothelial cell differentiation of human adipose tissue-derived stem cells | Q86545760 | ||
| 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs | Q87320818 | ||
| Tissue-engineered dermo-epidermal skin grafts prevascularized with adipose-derived cells | Q87551824 | ||
| 3D-printed vascular networks direct therapeutic angiogenesis in ischaemia | Q87997163 | ||
| Regulation of angiogenesis by hypoxia: role of the HIF system | Q29619187 | ||
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353189 | ||
| Endothelial cell sensing of flow direction | Q30410940 | ||
| An engineered muscle flap for reconstruction of large soft tissue defects | Q30428010 | ||
| Molecular determinants of vascular smooth muscle cell diversity | Q30435971 | ||
| Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction | Q30496577 | ||
| Fluid forces control endothelial sprouting. | Q30504415 | ||
| In vitro microvessels for the study of angiogenesis and thrombosis | Q30519206 | ||
| In vitro engineering of vascularized tissue surrogates | Q30536172 | ||
| Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues | Q30537022 | ||
| Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro | Q30539235 | ||
| In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels | Q30540002 | ||
| Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force | Q30540882 | ||
| Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. | Q30542133 | ||
| Vascular remodeling of the mouse yolk sac requires hemodynamic force | Q30606149 | ||
| Generation of 3D functional microvascular networks with human mesenchymal stem cells in microfluidic systems | Q30618514 | ||
| Three-Dimensional Vascular Network Assembly From Diabetic Patient-Derived Induced Pluripotent Stem Cells | Q30667815 | ||
| GATA4-dependent organ-specific endothelial differentiation controls liver development and embryonic hematopoiesis | Q30840166 | ||
| Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling | Q33537670 | ||
| Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization | Q33606829 | ||
| Rapid anastomosis of endothelial progenitor cell-derived vessels with host vasculature is promoted by a high density of cotransplanted fibroblasts | Q33617317 | ||
| Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function | Q33726792 | ||
| eNOS transfection of adipose-derived stem cells yields bioactive nitric oxide production and improved results in vascular tissue engineering | Q33728866 | ||
| Fluid shear stress threshold regulates angiogenic sprouting | Q33730496 | ||
| Control of perfusable microvascular network morphology using a multiculture microfluidic system | Q33820006 | ||
| Functional arteries grown in vitro | Q33858809 | ||
| Hif-1α regulates macrophage-endothelial interactions during blood vessel development in zebrafish | Q33860699 | ||
| Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds | Q34034589 | ||
| Genome-wide inactivation of porcine endogenous retroviruses (PERVs). | Q34045122 | ||
| Endothelial cells derived from human embryonic stem cells | Q34048189 | ||
| Human endothelial cell interaction with biomimetic surfactant polymers containing Peptide ligands from the heparin binding domain of fibronectin | Q34049420 | ||
| Hypoxia-inducible hydrogels | Q34167408 | ||
| Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs | Q34359576 | ||
| Infection of human cells by an endogenous retrovirus of pigs | Q34418546 | ||
| Regulation of cell adhesion and migration by cell-derived matrices | Q37191171 | ||
| Role of crosstalk between phosphatidylinositol 3-kinase and extracellular signal-regulated kinase/mitogen-activated protein kinase pathways in artery-vein specification | Q37271026 | ||
| Polymeric materials for tissue engineering of arterial substitutes | Q37271721 | ||
| Human Skin Constructs with Spatially Controlled Vasculature Using Primary and iPSC-Derived Endothelial Cells | Q37272276 | ||
| Tissue engineering of acellular vascular grafts capable of somatic growth in young lambs | Q37315053 | ||
| Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis | Q37346752 | ||
| Scaffold-free vascular tissue engineering using bioprinting | Q37356210 | ||
| Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. | Q37377991 | ||
| Organ printing: tissue spheroids as building blocks | Q37379489 | ||
| Sculpting the blank slate: how fibrin's support of vascularization can inspire biomaterial design | Q37394744 | ||
| Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature | Q37471583 | ||
| Vascular smooth muscle cell glycocalyx mediates shear stress-induced contractile responses via a Rho kinase (ROCK)-myosin light chain phosphatase (MLCP) pathway | Q37638030 | ||
| Low oxygen tension enhances endothelial fate of human pluripotent stem cells | Q37689156 | ||
| Infection of hemodialysis arteriovenous grafts. | Q37696414 | ||
| Engineering vascularized skeletal muscle tissue | Q34427542 | ||
| The global diffusion of organ transplantation: trends, drivers and policy implications | Q34446821 | ||
| The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy | Q34464741 | ||
| Relevance and safety of telomerase for human tissue engineering | Q34479476 | ||
| Cellular engineering of vascular bypass grafts: role of chemical coatings for enhancing endothelial cell attachment | Q34502426 | ||
| Developing functional musculoskeletal tissues through hypoxia and lysyl oxidase-induced collagen cross-linking | Q34526207 | ||
| Cellular and molecular basis of wound healing in diabetes | Q34625159 | ||
| Arterial-venous specification during development | Q34962630 | ||
| Cardiovascular tissue engineering | Q35013029 | ||
| Inflammation in cardiovascular tissue engineering: the challenge to a promise: a minireview | Q35094708 | ||
| Tissue engineering therapy for cardiovascular disease | Q35140518 | ||
| Modeling of microvascular permeability changes after electroporation | Q35203487 | ||
| Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis | Q35525477 | ||
| Patterning vascular networks in vivo for tissue engineering applications | Q35540080 | ||
| Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells. | Q35542968 | ||
| Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review | Q35577912 | ||
| siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown. | Q35590281 | ||
| Endothelial cell seeding of polymeric vascular grafts | Q35672748 | ||
| Fabrication of 3D Biomimetic Microfluidic Networks in Hydrogels | Q36033838 | ||
| Towards organ printing: engineering an intra-organ branched vascular tree | Q36086794 | ||
| Hypoxia-induced angiogenesis: good and evil | Q36137705 | ||
| Tissue engineering of vascular conduits. | Q36480242 | ||
| Myocardial ischemia-reperfusion injury: a neglected therapeutic target. | Q36497176 | ||
| Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. | Q36603422 | ||
| Three-dimensional bioprinting of thick vascularized tissues | Q36742689 | ||
| Cumulative patency of contemporary fistulas versus grafts (2000-2010). | Q36810446 | ||
| Geometric control of vascular networks to enhance engineered tissue integration and function | Q36835748 | ||
| Biodegradable scaffold with built-in vasculature for organ-on-a-chip engineering and direct surgical anastomosis | Q36932518 | ||
| Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. | Q37026285 | ||
| In vitro perfused human capillary networks | Q37035799 | ||
| Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney | Q37061068 | ||
| Hyaluronic acid hydrogels for biomedical applications | Q37063026 | ||
| Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix | Q37068457 | ||
| Functional vascular endothelium derived from human induced pluripotent stem cells. | Q37133657 | ||
| Three-dimensional biomimetic vascular model reveals a RhoA, Rac1, and N-cadherin balance in mural cell-endothelial cell-regulated barrier function | Q41476840 | ||
| Matrix degradability controls multicellularity of 3D cell migration | Q41550320 | ||
| The combination of stem cells and tissue engineering: an advanced strategy for blood vessels regeneration and vascular disease treatment | Q41718625 | ||
| Implantable tissue-engineered blood vessels from human induced pluripotent stem cells | Q42174272 | ||
| Investigating human vascular tube morphogenesis and maturation using endothelial cell-pericyte co-cultures and a doxycycline-inducible genetic system in 3D extracellular matrices | Q42186422 | ||
| Human tissue-engineered blood vessels for adult arterial revascularization | Q42382267 | ||
| Spatial control of cell-mediated degradation to regulate vasculogenesis and angiogenesis in hyaluronan hydrogels | Q42403000 | ||
| Bioprinting vessel-like constructs using hyaluronan hydrogels crosslinked with tetrahedral polyethylene glycol tetracrylates | Q42825781 | ||
| Late-term results of tissue-engineered vascular grafts in humans | Q43182712 | ||
| Hypoxic/normoxic preconditioning increases endothelial differentiation potential of human bone marrow CD133+ cells | Q43194615 | ||
| Hydrogels with precisely controlled integrin activation dictate vascular patterning and permeability | Q45064854 | ||
| Formation of microvascular networks in vitro | Q45102722 | ||
| Macrophage phenotype as a determinant of biologic scaffold remodeling | Q46298232 | ||
| Enhanced elastin synthesis and maturation in human vascular smooth muscle tissue derived from induced-pluripotent stem cells | Q46521119 | ||
| The effect of decellularization of tracheal allografts on leukocyte infiltration and of recellularization on regulatory T cell recruitment. | Q46879227 | ||
| A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells | Q46888349 | ||
| Cdh5/VE-cadherin promotes endothelial cell interface elongation via cortical actin polymerization during angiogenic sprouting | Q47073433 | ||
| A non-canonical Notch complex regulates adherens junctions and vascular barrier function | Q47328096 | ||
| Evaluation of a bioengineered construct for tissue engineering applications | Q47355987 | ||
| Human Pluripotent Stem Cells to Engineer Blood Vessels | Q47393306 | ||
| Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition. | Q47721296 | ||
| Blood vessel anastomosis is spatially regulated by Flt1 during angiogenesis. | Q48183560 | ||
| Impact of Detergent-Based Decellularization Methods on Porcine Tissues for Heart Valve Engineering | Q49076089 | ||
| Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro | Q49423373 | ||
| Hold Me, but Not Too Tight-Endothelial Cell-Cell Junctions in Angiogenesis. | Q50278294 | ||
| Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. | Q50693981 | ||
| In vivo analysis reveals a highly stereotypic morphogenetic pathway of vascular anastomosis. | Q50739175 | ||
| Engineered human vascularized constructs accelerate diabetic wound healing. | Q50794642 | ||
| Amplified Photodegradation of Cell-Laden Hydrogels via an Addition-Fragmentation Chain Transfer Reaction. | Q51033350 | ||
| Scaling laws of vascular trees: of form and function. | Q51360017 | ||
| Blood vessels engineered from human cells. | Q51430806 | ||
| Perfusion bioreactor for small diameter tissue-engineered arteries. | Q51643377 | ||
| A novel use of centrifugal force for cell seeding into porous scaffolds. | Q51712438 | ||
| Blood flow drives lumen formation by inverse membrane blebbing during angiogenesis in vivo. | Q52855491 | ||
| A short discourse on vascular tissue engineering. | Q52924173 | ||
| Hypoxia Promotes Efficient Differentiation of Human Embryonic Stem Cells to Functional Endothelium | Q57310803 | ||
| Surgical Considerations in the Treatment of Aneurysms of the Thoraco-abdominal Aorta | Q63984108 | ||
| Endothelialization of vascular prostheses by transplantation of venous tissue fragments | Q68622681 | ||
| Aorta-coronary bypass grafting with polytetrafluoroethylene conduits. Early and late outcome in eight patients | Q68823305 | ||
| A blood vessel model constructed from collagen and cultured vascular cells | Q69983909 | ||
| An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix | Q71034027 | ||
| Decreased Elastin Synthesis in Normal Development and in Long-term Aortic Organ and Cell Cultures Is Related to Rapid and Selective Destabilization of mRNA for Elastin | Q71807361 | ||
| Blood Supply of the Myocardium after Temporary Coronary Occlusion | Q72783959 | ||
| Transplantation of a tissue-engineered pulmonary artery | Q73548268 | ||
| Shear stress as an inhibitor of vascular smooth muscle cell proliferation. Role of transforming growth factor-beta 1 and tissue-type plasminogen activator | Q73707718 | ||
| A completely biological tissue-engineered human blood vessel | Q74075096 | ||
| Stent graft versus balloon angioplasty for failing dialysis-access grafts | Q82859955 | ||
| Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study | Q83732473 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tissue engineering | Q1540285 |
| P304 | page(s) | 340-354 | |
| P577 | publication date | 2018-03-01 | |
| P1433 | published in | Cell Stem Cell | Q2943975 |
| P1476 | title | Vascular Tissue Engineering: Progress, Challenges, and Clinical Promise. | |
| P478 | volume | 22 |
| Q64227923 | 3D printing approaches for cardiac tissue engineering and role of immune modulation in tissue regeneration |
| Q64966383 | Accurate flow in augmented networks (AFAN): an approach to generating three-dimensional biomimetic microfluidic networks with controlled flow. |
| Q57470597 | Bioengineering human vascular networks: trends and directions in endothelial and perivascular cell sources |
| Q92563829 | Biofabrication of thick vascularized neo-pedicle flaps for reconstructive surgery |
| Q92764608 | Bioprinting of freestanding vascular grafts and the regulatory considerations for additively manufactured vascular prostheses |
| Q64118890 | Brain Capillary Networks Across Species: A few Simple Organizational Requirements Are Sufficient to Reproduce Both Structure and Function |
| Q64229757 | Brain Organoids-A Bottom-Up Approach for Studying Human Neurodevelopment |
| Q91811749 | Cardiac tissue engineering: state-of-the-art methods and outlook |
| Q92672611 | Concise Review: Patency of Small-Diameter Tissue-Engineered Vascular Grafts: A Meta-Analysis of Preclinical Trials |
| Q90718914 | Engineering hiPSC cardiomyocyte in vitro model systems for functional and structural assessment |
| Q58120574 | Engineering molecular imaging strategies for regenerative medicine |
| Q90639971 | Engineering transferrable microvascular meshes for subcutaneous islet transplantation |
| Q90450099 | Generating vascular conduits: from tissue engineering to three-dimensional bioprinting |
| Q58698138 | It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease |
| Q91661092 | Multiscale bioprinting of vascularized models |
| Q89834577 | Recapitulating the Vasculature Using Organ-On-Chip Technology |
| Q93175196 | Spatial Patterning of Molecular Cues and Vascular Cells in Fully Integrated Hydrogel Channels via Interfacial Bioorthogonal Cross-Linking |
| Q92472519 | The ins and outs of engineering functional tissues and organs: evaluating the in-vitro and in-situ processes |
Search more.